JPMorgan analyst Benjamin Rossi raised the firm’s price target on InnovAge (INNV) to $7 from $5 and keeps an Underweight rating on the shares. The firm updated the company’s model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INNV:
- InnovAge Holding Corp. Delivers Profitable Earnings Rebound
- InnovAge, LeadingAge Colorado meet with state lawmakers on senior care
- Balanced Risk-Reward Keeps InnovAge at Hold Despite Strong Execution and Upgraded Outlook
- InnovAge reports Q2 EPS 8c vs. (10c) last year
- InnovAge raises FY26 revenue view to $925M-$950M from $915M-$940M